Učitavanje...

Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy

Pancreatic adenocarcinoma is a common malignancy that remains refractory to available therapies. Gemcitabine has long been the standard, first-line agent in advanced disease. The epidermal growth factor receptor (EGFR) is a commonly expressed target in pancreatic cancer that is involved in tumor pro...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Faller, Bryan A, Burtness, Barbara
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2009
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2747340/
https://ncbi.nlm.nih.gov/pubmed/19774209
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!